BLOG

Understanding Your NK Cell Therapy Medical Report from Japan

Published 2026.09.19 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

When seeking specialized medical care like NK Cell Therapy in another country, ensuring clear and continuous communication with your primary oncologist back home is essential. The key to bridging this geographical gap lies in a comprehensive medical report. This article explains what international patients can expect in medical reports from a Japanese clinic, helping you and your home doctor collaborate effectively on your health journey.

The primary purpose of these reports is to provide your home physician with transparent, detailed information about the immunotherapy you received. This allows them to integrate it into your overall treatment plan and make informed decisions about your ongoing care. A well-documented report is a cornerstone of responsible international medical tourism, ensuring continuity and safety.

Why Detailed Medical Reports are Crucial for International Care

For any patient undergoing cancer treatment, a complete medical history is vital. When a portion of that treatment occurs abroad, detailed reports are necessary to prevent information gaps. Your oncologist needs to understand the specifics of the NK cell therapy—such as the number and activity of the cells administered—to assess its role alongside other treatments you may be receiving, like chemotherapy or radiation. A report from a clinic in Japan, such as Grand Green Osaka Umekita Clinic, provides the necessary clinical data to ensure your care is cohesive and consistent across borders, facilitating effective and coordinated care internationally.

Key Components of an NK Cell Therapy Report in Japan

A medical report for NK cell therapy is a detailed account of a highly personalized process. While the exact format can vary, a thorough immunotherapy report from a reputable clinic will typically include several key sections to ensure clarity for your oncologist’s medical records.

Patient and Diagnostic Information: This section includes your personal details, a summary of your relevant medical history, and the specific diagnosis for which the therapy was administered.
Cell Processing and Quality Data: This is a critical part of the report. It documents the laboratory process, including the initial number of NK cells collected, the methods used for their activation and expansion, the final cell count prepared for infusion, and data on the purity and viability of the cells.
Treatment Administration Record: For each infusion, the report will log the date, the total number and volume of cells returned to your body, and any relevant observations made during or after the procedure.
Clinical Summary and Physician’s Notes: This section may include notes on your condition during the treatment period. It is important to understand that individual responses can vary. Potential side effects, such as a temporary, mild fever or fatigue, may be noted here if they occur.

This detailed information allows your home oncologist to have a clear and technical understanding of the cancer treatment in Japan you received.

How to Use Your Medical Report for Coordinated Care

Once you receive your medical report, sharing it effectively is the next step. Clinics in Japan that serve international patients, such as our facility in Osaka, typically provide reports in English. It is always a good practice to confirm this beforehand. We recommend scheduling a dedicated follow-up appointment with your home doctor specifically to review the report. This allows for a focused discussion about how the NK cell therapy fits into your broader treatment strategy and what the next steps for monitoring or follow-up care should be. This collaborative review ensures the treatment is an integrated part of your long-term health management, not an isolated event.

Understanding the Regulatory Framework in Japan

It is important for international patients to know that NK cell therapy in Japan is provided as a form of regenerative medicine. It is regulated under the country’s Act on the Safety of Regenerative Medicine. This means treatments are administered based on a plan that has been reviewed by a certified committee and submitted to the Ministry of Health, Labour and Welfare. Furthermore, cell processing occurs in facilities that meet stringent safety and quality standards. This regulatory framework ensures that the process is well-documented and transparent, which is reflected in the detailed reports provided to patients.

This therapy is a private medical service not covered by public health insurance. It is not intended to replace standard cancer treatments like surgery, chemotherapy, or radiation. Instead, it is often considered as a treatment that can be used in conjunction with them. The suitability, potential effects, risks, and side effects of the therapy differ for each individual and must be determined through a consultation with a physician.

Preparing for Your Consultation in Osaka

If you are considering NK cell therapy, the journey begins with a medical consultation. A physician will carefully review your medical history and current condition to determine if this therapy is a suitable option for you. This is your opportunity to ask questions about the process, the potential benefits and risks, and the type of reporting you will receive to share with your doctor at home.

At Grand Green Osaka Umekita Clinic, we prioritize clear communication with our international patients. For comprehensive information about the treatment flow, costs, potential risks, and side effects, we encourage you to review our detailed NK Cell Therapy page before your consultation. A final decision on treatment eligibility can only be made by a physician after a thorough assessment.

You can find more details on our dedicated page: NK Cell Therapy at Grand Green Osaka Umekita Clinic.

Conclusion: Ensuring Continuity of Care Across Borders

A comprehensive medical report is more than just a document; it is a vital tool for ensuring safe, continuous, and coordinated care when you travel for medical treatment. By providing your home oncologist with detailed data from your NK cell therapy in Japan, you empower your entire care team to work together. This transparent, collaborative approach is fundamental to navigating cancer treatment in today’s globalized world, ensuring that the care you receive is an integrated and well-understood part of your complete health plan.

Your NK Therapy Report from Japan

For Coordinated CareShare with your home doctor
Detailed Clinical DataCell quality, treatment records, etc
Regulated in JapanBased on official regulations
Used with Standard CareA private medical service

This diagram provides a simplified overview of the information in this article

Learn more about NK Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›